| AChE | Acetylcholinesterase |
| AhR | Aryl Hydrocarbon Receptor |
| AMH | Anti-Müllerian hormone |
| BALF | Bronchoalveolar Lavage Fluid |
| BMI | Body Mass Index |
| CEC | Contaminants of Emerging Concern |
| CNS | Central Nervous System |
| 2,8-DCDD | 2,8-dichlorodibenzo-p-dioxin |
| 2,4-DCP | 2,4-Dichlorophenol |
| EDCs | Endocrine Disrupting Chemicals |
| EDTA | Ethylenediaminetetraacetic Acid |
| ENR | Enoyl-acyl carrier Protein Reductase |
| EU | European Union |
| FASN | Fatty Acid Synthase Inhibitor |
| FDA | Food and Drug Administration |
| FSH | Follicle-stimulating hormone |
| FT3 | Triiodothyronine |
| FT4 | Thyroxine |
| GOT | Glutamic Oxaloacetic Transaminase |
| GPT | Glutamic Pyruvic Transaminase |
| HCC | Hepatocellular Carcinoma |
| HOME | Health Outcomes and Measures of the Environment |
| HUVEC | Human Umbilical Vein Endothelial Cell |
| IC50 | Half Minimal Inhibitory Concentration |
| IgE | Immunoglobulin E |
| IL-6 | Interleukin-6 |
| LU | Luteinizing hormone |
| LPS | Lipopolysaccharide |
| MIC | Minimum Inhibitory Concentration |
| MTCS | Methyltriclosan |
| NHANES | National Health and Nutrition Examination Surveys |
| OTC | Over-the-counter |
| PCOS | Polycystic Ovary Syndrome |
| PPCPs | Pharmaceutical and Personal Care Products |
| PVM/MA | Polyvinylmethyl Ether Maleic Acid |
| REACH | Registration, Evaluation, Authorisation and Restriction of Chemicals |
| ROS | Reactive Oxygen Species |
| SHIME | Simulator of the Human Intestinal Microbial Ecosystem |
| SSIs | Surgical Site Infections |
| TCC | Triclocarban |
| TCS | Triclosan |
| TNF-α | Tumor Necrosis Factor alpha |
| TP | Total Protein |
| TSH | Thyroid-stimulating hormone |
| UDP | Uridine diphosphate |
| UGTs | UDP-glucuronosyltransferases |